Roivant Sciences President and Immunovant CEO Eric Venker Reports Disposal of Common Shares
I'm PortAI, I can summarize articles.
Eric Venker, President of Roivant Sciences and CEO of Immunovant, has reported the disposal of common shares of Roivant Sciences Ltd. This information was published by Roivant Sciences Ltd. via the EDGAR system of the U.S. Securities and Exchange Commission on December 11, 2025. The news is generated by Public Technologies using AI and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments